SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Laboratories informs about newspaper advertisement

01 Feb 2023 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Chemo Pharma Laboratories has informed that it enclosed copies of the newspaper advertisement pertaining to financial results of the Company for the quarter and nine months ended December 31, 2022. This will also be posted on the company’s website at http://www.thechemopharmalaboratoriesltd.com

The above information is a part of company’s filings submitted to BSE.

Starsource Multitrad Share Price

110.70 -5.80 (-4.98%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×